Jazz Pharmaceuticals, a biopharmaceutical company specializing in products that address unmet medical needs, has appointed the following individuals to senior management positions:

Suzanne Sawochka Hooper will become general counsel and an executive officer. Hooper is currently a partner at Cooley, where she has practiced corporate and securities law since 1996. She has provided counsel to Jazz Pharmaceuticals for more than five years and was closely involved in the company's recent business combination with Azur Pharma.

Fintan Keegan has been appointed senior vice president of technical operations and will oversee the company's manufacturing, supply chain, quality and technical operations. Keegan was previously with Azur Pharma since 2006. He has over 27 years of experience in manufacturing and related technical operations.

Eunan Maguire will become senior vice president of strategy and corporate development and focus on the company's efforts to expand its product portfolio. Maguire was a co-founder of Azur Pharma and was president of U.S. operations. He has over 15 years of industry experience.